Internal Medicine, Gastroenterology · Boston, MA
NPI
1730492216
Since 2010
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
75 Francis St
Boston, MA, 02115
Phone (617) 732-6389
Groups this clinician bills Medicare through
Medicare paid, 2024
$55K
569 services
Medicare patients, 2024
264
Average age 71
Drug cost, 2024
$3.0M
436 prescriptions
Company payments, 2025
$3,790
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rachel Winter was code 99215 (office e&m - established), 90 times for 65 patients. In total Rachel Winter billed 569 services in 30 codes, and Medicare paid $55K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 90 | 65 | $129.99 | $12K |
| 45380 Lower GI Endoscopy - Other | Office | 81 | 81 | $84.49 | $6,844 |
| 99214 Office E&M - Established | Office | 76 | 67 | $89.51 | $6,802 |
| 45385 Colonoscopy - Lesion Removal | Office | 64 | 64 | $217.85 | $14K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 62 | 60 | $13.44 | $833 |
| 43239 Upper GI Endoscopy | Office | 46 | 46 | $66.99 | $3,081 |
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Office | 41 | 40 | $4.80 | $197 |
| 99223 Hospital E&M - Initial | Facility | 18 | 18 | $137.93 | $2,483 |
| 99232 Hospital E&M - Subsequent | Facility | 17 | 14 | $63.01 | $1,071 |
By year: 2022 $54K for 515 services; 2023 $60K for 541 services; 2024 $55K for 569 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rachel Winter prescribed most often to Medicare patients was Stelara (Ustekinumab), with 62 prescriptions and refills. In total Rachel Winter wrote 436 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Stelara Ustekinumab | 62 | 76 | Under 11 | $1.7M |
| Omeprazole Generic | 41 | 107 | 19 | $628 |
| Mesalamine Generic | 36 | 86 | 13 | $24K |
| Skyrizi On-Body Risankizumab-Rzaa | 29 | 49 | Under 11 | $567K |
| Azathioprine Generic | 21 | 29 | Under 11 | $921 |
| Entyvio Pen Vedolizumab | 19 | 28 | Under 11 | $168K |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 19 | 19 | 18 | $280 |
| Famotidine Generic | 18 | 53 | Under 11 | $300 |
| Xifaxan Rifaximin | 17 | 17 | Under 11 | $74K |
| Mesalamine Er Mesalamine | 16 | 48 | Under 11 | $10K |
| Humira(Cf) Adalimumab | 14 | 14 | Under 11 | $181K |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 12 | 16 | Under 11 | $174 |
| Humira(Cf) Pen Adalimumab | 11 | 11 | Under 11 | $136K |
| Sulfasalazine Generic | 11 | 11 | Under 11 | $63.48 |
Brand drugs: 190 claims; generic drugs: 246 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rachel Winter $3,790 ($3,790 in general payments such as food, travel and fees) from 3 companies. The largest payer was Celltrion USA Inc. with $3,177.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.